Fear of the unknown, and of being alone, are the worst of all fears, and, therefore, the biggest challenges in coping with progressive vision loss. Conquering those fears can open doors of opportunities never thought possible. As this month’s International Low Vision Support Group presenter, Dan Roberts, introduces his childhood monster and talks about how [Read More]
News
Seniors With Wet AMD Now Less Likely to Need Long-Term Care
Researchers have looked at a sample population of senior adults newly diagnosed with wet age-related macular degeneration (exudative, or neovascular, AMD) and found that those who received either Lucentis or Avastin injections* were 19% less likely to be admitted to a long-term care facility during the follow-up period. The reason? The introduction of anti-VEGF therapy [Read More]
Glaucoma: The "Silent Thief of Sight"
Courtesy: National Eye Institute, National Institutes of Health (NEI/NIH) Glaucoma is sometimes called the “silent thief of sight” because it slowly damages the eyes and can cause irreparable harm before there is any vision loss. But this disease is stealthy in more ways than one. Glaucoma has been known at least since antiquity, and yet, [Read More]
20 Things Eye Doctors Probably Don’t Tell You (But Would Like You To Know)
by Dan Roberts Optometrists and ophthalmologists are human. And like the rest of us humans, they can get tired, impatient, frustrated, despondent, and hurt. Unfortunately, professional decorum requires that they maintain a good front by either bottling up their thoughts or venting them at home–neither of which are necessarily good options. For that reason, I [Read More]
Findings Help Predict AMD Advancement
A 10-year follow-up study of participants in the original AREDS trial has been completed. The Age-Related Eye Disease Study Research Group revealed new statistics on the risk and rate of progression from early to advanced age-related macular degeneration (AMD). Participants aged 55 to 80 years with no AMD or AMD of varying severity were followed [Read More]